Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

UVA’s PEDAP-AI trial now recruiting for AI-assisted insulin pump settings in kids with type 1 diabetes ages 2-5 using Tandem pump and Dexcom CGM systems.
Tandem’s Mobi automated insulin delivery system has officially launched in the U.S. The world’s smallest insulin delivery system to be fully controlled by a smartphone...
The new Look AHEAD trial analysis shows major heart and kidney benefits for type 2 diabetes patients in remission, reshaping views on lifestyle changes.
New study in Diabetes, Obesity and Metabolism reveals Brenzavvy, an affordable SGLT-2 inhibitor for type 2 diabetes, is heart-safe and effective. It lowers blood sugar...
Vertex pauses VX-880 trial after two deaths; fate of diabetes treatment uncertain as current participants continue therapy.
Led by Dr. Jeremy Pettus, researchers at UC San Diego are investigating liver-targeted insulin in type 1 diabetes. Explore how this novel insulin could significantly...
Several trials are studying innovative approaches to help people living with diabetes better manage blood glucose levels with CGM, AID systems, and digital health. Here...
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
Discover how automated insulin delivery (AID) benefits type 1 diabetes and ongoing trials assessing the impact of AID systems on type 2 diabetes management.
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can...
The FINE-ONE trial by Bayer investigates Kerendia's effectiveness in preventing kidney disease progression in people with type 1 diabetes. This pivotal trial could...
Explore groundbreaking type 1 diabetes trials from stem cell therapies to novel drugs that aim to improve health outcomes. Be part of advancing type 1 diabetes treatment...
Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the...
Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
Vertex Pharmaceuticals is recruiting for a trial researching encapsulated stem cell therapy with the potential to restore insulin-producing islet cell function in people...
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.

Pages